A report on Malaria, Plasmodium falciparum and Antimalarial medication
Plasmodium falciparum is a unicellular protozoan parasite of humans, and the deadliest species of Plasmodium that causes malaria in humans.
- Plasmodium falciparumAntimalarial medications or simply antimalarials are a type of antiparasitic chemical agent, often naturally derived, that can be used to treat or to prevent malaria, in the latter case, most often aiming at two susceptible target groups, young children and pregnant women.
- Antimalarial medicationPractice in treating cases of malaria is most often based on the concept of combination therapy (e.g., using agents such as artemether and lumefantrine against chloroquine-resistant Plasmodium falciparum infection), since this offers advantages including reduced risk of treatment failure, reduced risk of developed resistance, as well as the possibility of reduced side-effects.
- Antimalarial medicationMost deaths are caused by P. falciparum, whereas P. vivax, P. ovale, and P. malariae generally cause a milder form of malaria.
- MalariaThe recommended treatment for malaria is a combination of antimalarial medications that includes artemisinin.
- MalariaAccording to WHO guidelines 2010, artemisinin-based combination therapies (ACTs) are the recommended first-line antimalarial treatments for uncomplicated malaria caused by P. falciparum.
- Plasmodium falciparum5 related topics with Alpha
Plasmodium
3 linksGenus of unicellular eukaryotes that are obligate parasites of vertebrates and insects.
Genus of unicellular eukaryotes that are obligate parasites of vertebrates and insects.
The ensuing destruction of host red blood cells can result in malaria.
Over the course of the 20th century, many other species were discovered in various hosts and classified, including five species that regularly infect humans: P. vivax, P. falciparum, P. malariae, P. ovale, and P. knowlesi.
A number of drugs have been developed to treat Plasmodium infection; however, the parasites have evolved resistance to each drug developed.
Plasmodium vivax
2 linksProtozoal parasite and a human pathogen.
Protozoal parasite and a human pathogen.
This parasite is the most frequent and widely distributed cause of recurring malaria.
Although it is less virulent than Plasmodium falciparum, the deadliest of the five human malaria parasites, P. vivax malaria infections can lead to severe disease and death, often due to splenomegaly (a pathologically enlarged spleen).
Where an artemisinin-based combination therapy has been adopted as the first-line treatment for P. falciparum malaria, it may also be used for P. vivax malaria in combination with primaquine for radical cure.
Artemisinin
2 linksArtemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum.
Artemisinin-based combination therapies (ACTs) are now standard treatment worldwide for P. falciparum malaria as well as malaria due to other species of Plasmodium.
Chloroquine
2 linksChloroquine is a medication primarily used to prevent and treat malaria in areas where malaria remains sensitive to its effects.
It is generally not used for Plasmodium falciparum as there is widespread resistance to it.
In areas where resistance is present, other antimalarials, such as mefloquine or atovaquone, may be used instead.
Artemisia annua
1 linksCommon type of wormwood native to temperate Asia, but naturalized in many countries including scattered parts of North America.
Common type of wormwood native to temperate Asia, but naturalized in many countries including scattered parts of North America.
An extract of A. annua, called artemisinin (or artesunate), is a medication used to treat malaria.
In 1971, scientists demonstrated the plant extracts had antimalarial activity in primate models, and in 1972, the active ingredient, artemisinin (formerly referred to as arteannuin), was isolated and its chemical structure described.
Malaria is caused by apicomplexans, primarily Plasmodium falciparum, which largely reside in red blood cells and contain iron-rich heme-groups (in the form of hemozoin).